Dr. Iris Marin Collazo, MD

Dr. Marin Collazo practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Marin Collazo's NPI, 1275890873, was assigned on April 19, 2012. Dr. Marin Collazo graduated from Universidad Central del Caribe School of Medicine in 2012. Dr. Marin Collazo holds Florida license ME117021.

Dr. Marin Collazo's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Marin Collazo's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marin Collazo practices. Vendor and product names are available with a free account.

Neurology is Dr. Marin Collazo's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Marin Collazo is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Marin Collazo's licenses on file in 2 states: Florida and Minnesota.

Dmand AI lists epilepsy, fibromyalgia and chronic pain, lower back pain, migraine and chronic headache, mobility impairment, multiple sclerosis, muscle pain, fibromyalgia, and limb pain and neuropathy among the conditions Dr. Marin Collazo treats.

CMS data shows 177 Medicare services from Dr. Marin Collazo across 5 procedure codes in 2024, for 166 Medicare patients. Medicare paid $14,981 for them. Every service was in an office.

CMS counts 166 Medicare patients who saw Dr. Marin Collazo in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marin Collazo's median patient age at 52, with 70% women.

In 2024, Dr. Marin Collazo wrote 318 Medicare Part D claims for 58 patients. 71% of them were for generic drugs. CMS names the drug for 163 of them, across 9 drugs with 11 or more claims each, at $123,892 in total drug cost. In 2023, CMS named 197 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Marin Collazo for performance year 2024, reported as part of a group. Dr. Marin Collazo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marin Collazo as offering telehealth.

Dmand AI links 5 papers to Dr. Marin Collazo in 2018. The most frequent topics are Magnetic Resonance Imaging. Dr. Marin Collazo has published most often in Neurologist. Dr. Marin Collazo's most frequent co-authors are Eric Eggenberger, DO, William D. Freeman, MD and Josephine Huang, MD.

CMS Open Payments shows 121 general payments to Dr. Marin Collazo from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Horizon Pharma plc paid the most, $11,126. It also lists 13 research payments totaling $1,556 in 2024, naming 1 clinical trial.

Dr. Marin Collazo graduated from Universidad Central del Caribe School of Medicine in 2012.

Dr. Marin Collazo is in network with 7 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.